Huntington National Bank’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$81.6K Hold
1,300
﹤0.01% 1153
2025
Q4
$124K Hold
1,300
﹤0.01% 909
2025
Q3
$127K Hold
1,300
﹤0.01% 907
2025
Q2
$140K Sell
1,300
-4,000
-75% -$405K ﹤0.01% 846
2025
Q1
$535K Buy
+5,300
New +$534K ﹤0.01% 509

Other funds holding BSX

Huntington National Bank's BSX Position: Q1 2026 in Review

Huntington National Bank reduced its Boston Scientific (BSX) stake by 1.6% in Q1 2026, selling an estimated $1.82M and leaving 1,405,328 shares worth $88.2M. The position accounts for 0.49% of the portfolio, ranked #60.

Huntington National Bank first reported a position in BSX in Q2 2013 and has held it in 49 quarters since. The position peaked at $149M in Q2 2025. 1,667 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Huntington National Bank held 1,405,328 shares of Boston Scientific worth $88.2M as of Q1 2026.
  • Huntington National Bank sold 22,806 Boston Scientific shares in Q1 2026, an estimated $1.82M.
  • Boston Scientific made up 0.49% of Huntington National Bank's portfolio in Q1 2026, its #60 holding.
  • Huntington National Bank first reported a position in Boston Scientific in Q2 2013 and has held it in 49 quarters since.
  • Huntington National Bank's Boston Scientific position peaked at $149M in Q2 2025.
  • 1,667 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.